Fig. 3
From: Scleritis following intravitreal brolucizumab injection: a case series
Clinical findings in Case 3. A Scleritis was observed after a fourth intravitreal brolucizumab injection. B Fundus images shows no vitreous opacity. C Fluorescein angiography and indocyanine green angiography did not show retinal vasculitis or retinal vascular occlusion. Optical coherence tomography showed fibrosis at the fovea centralis. D Scleritis gradually improved